Global Biologics (GB) mission is the discovery of transformative innovative biologics therapeutics to support Takeda’s pipeline and advance novel therapeutics into clinical development in Takeda’s three therapeutic areas of interest: Oncology, Gastroenterology and Neuroscience. Biologics In Vitro Pharmacology (BIVP) role is to identify the therapeutics candidates that have the desired biological activity and select the best candidates for further preclinical and clinical development. This role will provide essential scientific guidance and make strategic decisions to ensure the delivery of the critical functions of BIVP.